Invesco Ltd. Ardelyx, Inc. Transaction History

Invesco Ltd.

$557 Billion
Q2 2025

A detailed history of Invesco Ltd. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 229,676 shares of ARDX stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

229,676

Previous 177,529 29.37%

Holding current value

$1.21 Million

Previous $871,000 3.33%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$3.28 - $5.51 $171,042 - $287,329	52,147 Added 29.37%	229,676 $900,000
Q1 2025 May 12, 2025	BUY	$4.91 - $6.36 $258,187 - $334,434	52,584 Added 42.09%	177,529 $871,000
Q4 2024 Feb 13, 2025	BUY	$4.49 - $6.85 $47,207 - $72,020	10,514 Added 9.19%	124,945 $645,000
Q3 2024 Nov 12, 2024	BUY	$5.28 - $7.57 $9,826 - $14,087	1,861 Added 1.65%	114,431 $788,000
Q2 2024 Aug 13, 2024	SELL	$5.89 - $9.31 $16,050 - $25,369	-2,725 Reduced 2.36%	112,570 $834,000
Q1 2024 May 14, 2024	SELL	$6.05 - $9.74 $13.4 Million - $21.6 Million	-2,217,832 Reduced 95.06%	115,295 $841,000
Q4 2023 Feb 12, 2024	BUY	$3.29 - $6.64 $3.19 Million - $6.44 Million	970,148 Added 71.18%	2,333,127 $14.5 Million
Q3 2023 Nov 13, 2023	BUY	$3.3 - $4.83 $4.11 Million - $6.01 Million	1,244,734 Added 1052.67%	1,362,979 $5.56 Million
Q2 2023 Aug 11, 2023	SELL	$3.23 - $4.95 $3.28 Million - $5.02 Million	-1,014,059 Reduced 89.56%	118,245 $400,000
Q1 2023 May 12, 2023	BUY	$2.68 - $4.79 $2.99 Million - $5.34 Million	1,115,133 Added 6494.28%	1,132,304 $5.42 Million
Q4 2022 Feb 13, 2023	BUY	$1.22 - $2.85 $20,948 - $48,937	17,171 New	17,171 $48,000
Q2 2022 Aug 15, 2022	SELL	$0.51 - $1.17 $15,250 - $34,985	-29,902 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.65 - $1.18 $186 - $338	-287 Reduced 0.95%	29,902 $32,000
Q4 2021 Feb 14, 2022	SELL	$0.86 - $1.7 $7,392 - $14,613	-8,596 Reduced 22.16%	30,189 $33,000
Q3 2021 Nov 15, 2021	BUY	$1.27 - $8.17 $8,004 - $51,495	6,303 Added 19.4%	38,785 $51,000
Q2 2021 Aug 17, 2021	BUY	$6.55 - $8.98 $102,854 - $141,012	15,703 Added 93.59%	32,482 $247,000
Q1 2021 May 17, 2021	BUY	$6.1 - $7.69 $21,813 - $27,499	3,576 Added 27.08%	16,779 $111,000
Q4 2020 Feb 16, 2021	BUY	$5.05 - $7.1 $66,675 - $93,741	13,203 New	13,203 $86,000
Q2 2020 Aug 14, 2020	SELL	$5.37 - $8.11 $587,907 - $887,882	-109,480 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$4.35 - $8.79 $338,364 - $683,730	-77,785 Reduced 41.54%	109,480 $622,000
Q4 2019 Feb 14, 2020	BUY	$4.23 - $8.29 $792,130 - $1.55 Million	187,265 New	187,265 $1.41 Million
Q1 2019 May 15, 2019	SELL	$1.88 - $3.35 $21,721 - $38,705	-11,554 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.66 - $4.16 $19,179 - $48,064	11,554 New	11,554 $21,000

Others Institutions Holding ARDX

# of Institutions

222

Shares Held

167M

Call Options Held

517K

Put Options Held

1.61M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $816M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account